GADD45G and myeloproliferative neoplasm: The reintroduction of Gadd45g prominently prolonged the survival and reduced the morbidity of the recipient mice (Fig. 4k, Supplementary Table 1), confirming the causal role of Gadd45g deficiency in the development of MPN in mice.